Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is IPIX ready to move on from Covid and focus back on other ailments?
ClayTrader in 3...2....1
Let’s get closer to July...daily grind is not my concern.
$1.50’s will seem cheap when it clips $2.00
Ipix is still a .21 cent stock, and dilution continues.
90% trial enrollment. Pfizer is probably getting nervous now so they might consider buying IPIX for .60 cents a share... hahahahahaha Dilution was painful for the long investor here.
500 million outstanding shares reached this year?
The years go by and the salaries must be paid.
When will their be new leadership?
FDA will compelled to approve, they have wanted more antibiotics in the pipeline. I believe approval is imminent in July.
This will hit some radars next week..
Iterum Therapeutics Provides Update on NDA Review
Download as PDF May 27, 2021
DUBLIN, Ireland and CHICAGO, May 27, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company participated in a late-cycle meeting with the U.S. Food and Drug Administration (“FDA”) yesterday. During the meeting, the FDA shared issues still under review regarding the Company’s new drug application (“NDA”) for sulopenem etzadroxil/probenecid for the treatment of uncomplicated urinary tract infections in patients with a quinolone non-susceptible pathogen and the Company responded to these issues. The FDA has determined that an Advisory Committee meeting is not currently necessary. The review of the NDA is ongoing and the Company was informed that the FDA continues to work toward the PDUFA goal date of July 25, 2021.
About Iterum Therapeutics plc
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications.
Boom......$ITRM
Ipix stock price in a quagmire
FDA PDUFA goal date July 25, 2021
“.. Balance at March 31, 2021: 418,157,142”
What’s the cap 600,000,000 shares?
Kevetrin, why is it not in trials?
Look into Pfizer’s antiviral candidate PF-07321332, a SARS-CoV2-3CL protease inhibitor.
Ipix needs to move faster. Ipix needs an experienced chief medical officer IMO.
LET THAT SOAK IN! 1.9% prevalence rate in the US
Vaccines work! Prevalence rate in the US is 1.9%
Prevalence rate in the US is 1.9%
So what’s next?
Where is Dr Menon?
Why was he terminated?
Has that lawsuit settled yet??
Covid is winding down....now what.
Sticky worthy post. Might I add, Dr. Menon was terminated.
I see a pattern.
Pfizer is making an Antiviral medicine! Vaccine first and now their antiviral.
Brilacidin should move on.
Pfizer is a monster!!!!
Probably since they have been looking to partner or sell Brilacidin since ABSSI P2B.
Where is the Board of Directors?
Time to run another Phase 2 trial?
10-Q released ....oooohhh boy
Parachute time on this run?
Did Elon Musk mention Brilacidin on SNL?
Excellent! Thank you for the analysis.
Where does the price go if .20 doesn’t hold?
Ipix is slower than Pfizer. https://www.forbes.com/sites/tommybeer/2021/04/27/pfizer-ceo-says-antiviral-pill-to-treat-covid-could-be-ready-by-end-of-the-year/?sh=28558fd82a0d
“TOPLINE A pill that can be ingested orally at home to combat Covid-19 when illness is first detected could be available to the public by the end of 2021, Pfizer CEO Albert Bourla told CNBC on Tuesday, noting that the antiviral treatment is expected to be effective against variants of the virus.”
Pfizer CEO Says Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year
What’s going on?
Why not?
Pump those PR’s out.
Where is Kevetrin ?
10-Q due next month. This seems carefully timed. Raising funds today I bet.
I hope the trial is a great success.
The dilution is a concern.
ABSOLUTELY!!!!! I couldn’t agree more. Go Ipix.
Looks grim. Seems as if all hopes rest on a Phase 2 of a B-Covid trial. Feels like 50 cents is the new $1.
Litigation is still pending between Dr Menon and Ipix per the last quarterly report.